Original Research

Published on 26 Sep 2022

SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway

in Renal Pharmacology

Ruixue Guo
Peipei Wang
Xuejun Zheng
Wen Cui
Jin Shang
Zhanzheng Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.897167

4,642 views
15 citations

Original Research

Published on 26 Sep 2022

GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49

in Renal Pharmacology

Jinhong Ren
Huizhi Wei
Jian Sun
Xiue Feng
Yuanlin Zhang
Hongxia Yuan
Junqiu Miao
Xiaoming Qi
Yuanbiao Qiao
Baoguo Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.925489

1,939 views
3 citations

Original Research

Published on 23 Sep 2022

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

in Renal Pharmacology

Qian Huang
Rui Xiao
Jing Lu
Yao Zhang
Liang Xu
Jie Gao
Jing Sun
Haiping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973182

2,300 views
4 citations

Original Research

Published on 23 Sep 2022

Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice

in Renal Pharmacology

Jia Chen
Qingyun Zhou
Ying Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.946392

3,725 views
2 citations

Original Research

Published on 23 Sep 2022

Crosstalk between TBK1/IKKε and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury

in Renal Pharmacology

Gina Córdoba-David
Jorge García-Giménez
Regiane Cardoso Castelo-Branco
Susana Carrasco
Pablo Cannata
Alberto Ortiz
Adrián M. Ramos

Frontiers in Pharmacology

doi 10.3389/fphar.2022.987979

4,519 views
6 citations

Mini Review

Published on 22 Sep 2022

Future insights of pharmacological prevention for AKI post cardiopulmonary bypass surgery (based on PK/PD approach)

in Renal Pharmacology

Dias Permeisari

Frontiers in Pharmacology

doi 10.3389/fphar.2022.975641

2,503 views
3 citations

Hypothesis and Theory

Published on 21 Sep 2022

MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

in Renal Pharmacology

Xiaoshan Zhou
Haoran Dai
Hanxue Jiang
Hongliang Rui
Wenbin Liu
Zhaocheng Dong
Na Zhang
Qihan Zhao
Zhendong Feng
Yuehong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.968256

3,181 views
4 citations

Review

Published on 21 Sep 2022

The controversy of klotho as a potential biomarker in chronic kidney disease

in Renal Pharmacology

Li-Xia Yu
Sha-Sha Li
Min-Yue Sha
Jia-Wei Kong
Jian-Ming Ye
Qi-Feng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.931746

8,356 views
23 citations

Systematic Review

Published on 16 Sep 2022

Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis

in Renal Pharmacology

Shan Chong
Qiufen Xie
Tiantian Ma
Qian Xiang
Ying Zhou
Yimin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967532

3,379 views
2 citations

Systematic Review

Published on 16 Sep 2022

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease

in Renal Pharmacology

Yichuan Wu
Huanjia Lin
Yuan Tao
Ying Xu
Jiaqi Chen
Yijie Jia
Zongji Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967317

5,406 views
7 citations

Review

Published on 15 Sep 2022

Sepsis-induced AKI: From pathogenesis to therapeutic approaches

in Renal Pharmacology

Fang-Fang He
Yu-Mei Wang
Yi-Yuan Chen
Wei Huang
Zi-Qi Li
Chun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.981578

25,455 views
27 citations

Original Research

Published on 14 Sep 2022

Bibliometric and visual analysis of nephrotoxicity research worldwide

in Renal Pharmacology

Tianmu He
Jingwen Ao
Cancan Duan
Rong Yan
Xiaomei Li
Liu Liu
Jianyong Zhang
Xiaofei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940791

3,847 views
8 citations

Original Research

Published on 14 Sep 2022

Efficacy and safety of tailin formulation combined with continuous low-dose antibiotic therapy in patients with recurrent urinary tract infection: A multicenter, randomized, controlled clinical trial

in Renal Pharmacology

Tonglu Li
Yingru Xu
Gang Yuan
Wen Lu
Guihua Jian
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.968980

1,820 views
1 citation

Review

Published on 13 Sep 2022

Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy

in Renal Pharmacology

Hua Miao
Yamei Zhang
Xiaoyong Yu
Liang Zou
Yingyong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.969930

4,916 views
21 citations

Original Research

Published on 12 Sep 2022

SIRT6 overexpression retards renal interstitial fibrosis through targeting HIPK2 in chronic kidney disease

in Renal Pharmacology

Xiaoxue Li
Wenxin Li
Zhengzhipeng Zhang
Weidong Wang
Hui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007168

3,875 views
13 citations

Review

Published on 12 Sep 2022

Emerging role of extracellular vesicles in kidney diseases

in Renal Pharmacology

Huiling Xiang
Chun Zhang
Jing Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.985030

2,926 views
5 citations

Navigation group

Articles

SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway

GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice

Crosstalk between TBK1/IKKε and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury

Future insights of pharmacological prevention for AKI post cardiopulmonary bypass surgery (based on PK/PD approach)

MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

The controversy of klotho as a potential biomarker in chronic kidney disease

Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease

Sepsis-induced AKI: From pathogenesis to therapeutic approaches

Bibliometric and visual analysis of nephrotoxicity research worldwide

Efficacy and safety of tailin formulation combined with continuous low-dose antibiotic therapy in patients with recurrent urinary tract infection: A multicenter, randomized, controlled clinical trial

Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy

SIRT6 overexpression retards renal interstitial fibrosis through targeting HIPK2 in chronic kidney disease

Emerging role of extracellular vesicles in kidney diseases